company background image
BIOM3 logo

Biomm BOVESPA:BIOM3 Stock Report

Last Price

R$10.07

Market Cap

R$1.3b

7D

87.9%

1Y

112.0%

Updated

25 Feb, 2024

Data

Company Financials

Biomm S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Biomm
Historical stock prices
Current Share PriceR$10.07
52 Week HighR$10.20
52 Week LowR$3.10
Beta0.66
1 Month Change87.17%
3 Month Change67.83%
1 Year Change112.00%
3 Year Change-32.82%
5 Year Change52.58%
Change since IPO1,338.57%

Recent News & Updates

Biomm S.A.'s (BVMF:BIOM3) Share Price Is Matching Sentiment Around Its Revenues

Feb 21
Biomm S.A.'s (BVMF:BIOM3) Share Price Is Matching Sentiment Around Its Revenues

Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Nov 12
Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Recent updates

Biomm S.A.'s (BVMF:BIOM3) Share Price Is Matching Sentiment Around Its Revenues

Feb 21
Biomm S.A.'s (BVMF:BIOM3) Share Price Is Matching Sentiment Around Its Revenues

Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Nov 12
Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

We Think Biomm (BVMF:BIOM3) Has A Fair Chunk Of Debt

Jul 25
We Think Biomm (BVMF:BIOM3) Has A Fair Chunk Of Debt

Positive Sentiment Still Eludes Biomm S.A. (BVMF:BIOM3) Following 26% Share Price Slump

Apr 17
Positive Sentiment Still Eludes Biomm S.A. (BVMF:BIOM3) Following 26% Share Price Slump

Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Feb 28
Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Oct 15
Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt

Biomm (BVMF:BIOM3) Is Carrying A Fair Bit Of Debt

Jun 29
Biomm (BVMF:BIOM3) Is Carrying A Fair Bit Of Debt

We Think Biomm (BVMF:BIOM3) Has A Fair Chunk Of Debt

Aug 17
We Think Biomm (BVMF:BIOM3) Has A Fair Chunk Of Debt

Here's Why Biomm (BVMF:BIOM3) Can Afford Some Debt

Apr 05
Here's Why Biomm (BVMF:BIOM3) Can Afford Some Debt

Biomm (BVMF:BIOM3) Shareholders Have Enjoyed An Impressive 173% Share Price Gain

Mar 01
Biomm (BVMF:BIOM3) Shareholders Have Enjoyed An Impressive 173% Share Price Gain

Do Institutions Own Biomm S.A. (BVMF:BIOM3) Shares?

Jan 25
Do Institutions Own Biomm S.A. (BVMF:BIOM3) Shares?

Is Biomm (BVMF:BIOM3) A Risky Investment?

Dec 21
Is Biomm (BVMF:BIOM3) A Risky Investment?

Shareholder Returns

BIOM3BR BiotechsBR Market
7D87.9%1.7%0.4%
1Y112.0%1.6%17.0%

Return vs Industry: BIOM3 exceeded the BR Biotechs industry which returned 1.6% over the past year.

Return vs Market: BIOM3 exceeded the BR Market which returned 17% over the past year.

Price Volatility

Is BIOM3's price volatile compared to industry and market?
BIOM3 volatility
BIOM3 Average Weekly Movement14.2%
Biotechs Industry Average Movement9.3%
Market Average Movement4.6%
10% most volatile stocks in BR Market7.9%
10% least volatile stocks in BR Market2.4%

Stable Share Price: BIOM3's share price has been volatile over the past 3 months.

Volatility Over Time: BIOM3's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of BR stocks.

About the Company

FoundedEmployeesCEOWebsite
2001127Heraldo Marchezinihttps://www.biomm.com

Biomm S.A. operates as a biotechnology company in Brazil. It offers AFREZZA, a human insulin inhalation powder; GHEMAXAN, an enoxaparina sodica; GLARGILIN, a glargine insulin; WOSULIN R, a human insulin; WOSULIN N, an isophane insulin; HERZUMA, a trastuzumab; and CANETA LIFEPEN G PARA APLICACAO DE INSULINA. The company was founded in 2001 and is headquartered in Nova Lima, Brazil.

Biomm S.A. Fundamentals Summary

How do Biomm's earnings and revenue compare to its market cap?
BIOM3 fundamental statistics
Market capR$1.28b
Earnings (TTM)-R$82.37m
Revenue (TTM)R$124.50m

10.3x

P/S Ratio

-15.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOM3 income statement (TTM)
RevenueR$124.50m
Cost of RevenueR$101.74m
Gross ProfitR$22.76m
Other ExpensesR$105.14m
Earnings-R$82.37m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Mar 27, 2024

Earnings per share (EPS)-0.65
Gross Margin18.28%
Net Profit Margin-66.16%
Debt/Equity Ratio157.6%

How did BIOM3 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.